Company / Free Cash Flow
Avantor Free Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$495.0M
FY2025
5-year range
$495.0M / $868.2M
FY2021-FY2025
Trend
-28.5%
vs FY2024
Sector context
#41 of 151
Health Care
What the data says
At $495M, Avantor's free cash flow ranks #41 of 151 in the Health Care sector. Free Cash Flow has declined for 3 consecutive years, from $868M in FY2022 to $495M in FY2025.
Based on SEC 10-K filings.
$495M in FY2025 with a 5-year CAGR of -10.6%.
Declined from $724M to $495M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -17.1%
- 5-Year CAGR
- -10.6%
- 10-Year CAGR
- -
Sector benchmark
#41 of 151 in Health CareTop 27% of 151This company $495.0M Sector average $779.8M
▼
-36.5% below sector average
Key checks
Key Insights
- Avantor's free cash flow has declined for 3 consecutive years.
- 5-year CAGR of -10.6%, indicating a declining trend.
- In FY2025, free cash flow decreased 28.5% year-over-year.
- Ranks #41 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $495.0M | -28.5% |
| FY2024 | $692.0M | -4.4% |
| FY2023 | $723.6M | -16.7% |
| FY2022 | $868.2M | +3.1% |
| FY2021 | $842.5M | -3.0% |
| FY2020 | $868.2M | +550.5% |
| FY2019 | -$192.7M | -218.4% |
| FY2018 | $162.8M | +184.5% |
| FY2017 | -$192.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026